Kevin L. Law
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 4
-
- Pharmacological Effects and Toxicity Studies 2
-
- Click Chemistry and Applications 2
-
- Monoclonal and Polyclonal Antibodies Research 3
- Radiopharmaceutical Chemistry and Applications 2
-
- Cancer therapeutics and mechanisms 2
- Protein purification and stability 2
-
- Pediatric Hepatobiliary Diseases and Treatments 2
- Co-authors
- James J. StarlingAnne H. DantzigDamon L. MeyerStephen D. MikolajczykBryan H. NormanLouis N. JungheimJoseph M. GruberJulian S. Kroin
- Partner nations
- United States
In The Last Decade
Kevin L. Law
11 papers receiving 427 citations
Peers
Comparison fields: 5 of 63
- Oncology 233
- Biomaterials 47
- Pediatrics, Perinatology and Child Health 70
- Organic Chemistry 99
- Infectious Diseases 63
Countries citing papers authored by Kevin L. Law
This map shows the geographic impact of Kevin L. Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin L. Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin L. Law more than expected).
Fields of papers citing papers by Kevin L. Law
This network shows the impact of papers produced by Kevin L. Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin L. Law. The network helps show where Kevin L. Law may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin L. Law, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 94 | |
| 2 | 2005 | 49 | |
| 3 | 2002 | 55 | |
| 4 | 1999 | 23 | |
| 5 | 1997 | 70 | |
| 6 | 1996 | 30 | |
| 7 | 1996 | 12 | |
| 8 | 1995 | 25 | |
| 9 | 1994 | 26 | |
| 10 | Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models. | 1993 | 49 |
| 11 | 1987 | 11 |
About Kevin L. Law
Kevin L. Law is a scholar working on Physiology, Oncology and Biochemistry, having authored 11 papers that have together received 444 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer therapeutics and mechanisms (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Click Chemistry and Applications (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers) and Protein purification and stability (2 papers). The work is most often cited by research in Oncology (233 citations), Biomaterials (47 citations) and Pediatrics, Perinatology and Child Health (70 citations). Kevin L. Law has collaborated with scholars based in United States. Frequent co-authors include James J. Starling, Anne H. Dantzig, Damon L. Meyer, Stephen D. Mikolajczyk, Bryan H. Norman, Louis N. Jungheim, Joseph M. Gruber, Julian S. Kroin, Linda B. Tabas and Timothy A. Shepherd.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.